Ion channels induced by the prion protein: Mediators of neurotoxicity

Prion

Volumn 6, Issue 1, 2012, Pages 40-45

  Solomon, Isaac H ^a   Biasini, Emiliano ^a   Harris, David A ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Ion channel; Model; Neurodegeneration; Prion; Toxicity

Indexed keywords

ION CHANNEL; PRION PROTEIN;

AMINO TERMINAL SEQUENCE; BETA SHEET; BRAIN DISEASE; CELL CULTURE; CELL DEATH; ELECTROPHYSIOLOGY; GENE DELETION; HYPERSENSITIVITY; IMMUNOFLUORESCENCE; ION CURRENT; MEMBRANE POTENTIAL; MOLECULAR MECHANICS; NEUROTOXICITY; NONHUMAN; NOTE; POINT MUTATION; PRION DISEASE;

AMINO ACID SEQUENCE; ANIMALS; CELL MEMBRANE; HUMANS; ION CHANNEL GATING; ION CHANNELS; MICE; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; MUTATION; NEUROTOXICITY SYNDROMES; PRIONS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84857198808     PISSN: 19336896     EISSN: 1933690X     Source Type: Journal    
DOI: 10.4161/pri.6.1.18627     Document Type: Note

References (40)

1. Prusiner SB, Ed. Prion Biology and Diseases. Cold Spring Harbor: Cold Spring Harbor Laboratory Press 1999.
2. Prusiner SB. Prions. Proc Natl Acad Sci USA 1998; 95:13363-83; PMID:9811807; http://dx.doi.org/10.1073/pnas.95.23.13363.
3. Race R, Raines A, Raymond GJ, Caughey B, Chesebro B. Long-term subclinical carrier state precedes scrapie replication and adaptation in a resistant species: analogies to bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease in humans. J Virol 2001; 75:10106-12; PMID:11581378; http://dx.doi.org/10.1128/JVI.75.21.10106-12.2001.
4. Hill AF, Joiner S, Linehan J, Desbruslais M, Lantos PL, Collinge J. Species-barrier-independent prion replication in apparently resistant species. Proc Natl Acad Sci USA 2000; 97:10248-53; PMID:10963685; http://dx.doi.org/10. 1073/pnas.97.18.10248.
5. Lasmézas CI, Deslys JP, Robain O, Jaegly A, Beringue V, Peyrin JM, et al. Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein. Science 1997; 275:402-5; PMID:8994041; http://dx.doi.org/10.1126/science.275.5298.402.
6. Manson JC, Jamieson E, Baybutt H, Tuzi NL, Barron R, McConnell I, et al. A single amino acid alteration (101L) introduced into murine PrP dramatically alters incubation time of transmissible spongiform encephalopathy. EMBO J 1999; 18:6855-64; PMID:10581259; http://dx.doi.org/10.1093/emboj/18.23.6855.
7. Büeler H, Fischer M, Lang Y, Bluethmann H, Lipp HP, DeArmond SJ, et al. Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 1992; 356:577-82; PMID:1373228; http://dx.doi.org/10.1038/ 356577a0.
8. Harris DA, True HL. New insights into prion structure and toxicity. Neuron 2006; 50:353-7; PMID:16675391; http://dx.doi.org/10.1016/j.neuron. 2006.04.020.
9. Brandner S, Isenmann S, Raeber A, Fischer M, Sailer A, Kobayashi Y, et al. Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature 1996; 379:339-43; PMID:8552188; http://dx.doi.org/10.1038/379339a0.
10. Chesebro B, Race B, Meade-White K, Lacasse R, Race R, Klingeborn M, et al. Fatal transmissible amyloid encephalopathy: a new type of prion disease associated with lack of prion protein membrane anchoring. PLoS Pathog 2010; 6:1000800; PMID:20221436; http://dx.doi.org/10.1371/journal.ppat.1000800.
11. Li A, Christensen HM, Stewart LR, Roth KA, Chiesa R, Harris DA. Neonatal lethality in transgenic mice expressing prion protein with a deletion of residues 105-125. EMBO J 2007; 26:548-58; PMID:17245437; http://dx.doi.org/10. 1038/sj.emboj.7601507.
12. Christensen HM, Harris DA. A deleted prion protein that is neurotoxic in vivo is localized normally in cultured cells. J Neurochem 2009; 108:44-56; PMID:19046329; http://dx.doi.org/10.1111/j.1471-4159.2008.05719.x.
13. Massignan T, Stewart RS, Biasini E, Solomon IH, Bonetto V, Chiesa R, et al. A novel, drug-based, cellular assay for the activity of neurotoxic mutants of the prion protein. J Biol Chem 2010; 285:7752-65; PMID:19940127; http://dx.doi.org/10.1074/jbc.M109.064949.
14. Marcotti W, van Netten SM, Kros CJ. The aminoglycoside antibiotic dihydrostreptomycin rapidly enters mouse outer hair cells through the mechano-electrical transducer channels. J Physiol 2005; 567:505-21; PMID:15994187; http://dx.doi.org/10.1113/jphysiol.2005.085951.
15. Myrdal SE, Steyger PS. TRPV1 regulators mediate gentamicin penetration of cultured kidney cells. Hear Res 2005; 204:170-82; PMID:15925202; http://dx.doi.org/10.1016/j.heares.2005.02.005.
16. Massignan T, Biasini E, Harris DA. A Drug-Based Cellular Assay (DBCA) for studying cytotoxic and cytoprotective activities of the prion protein: A practical guide. Methods 2011; 53:214-9; PMID:21115124; http://dx.doi.org/10. 1016/j.ymeth.2010.11.005.
17. Solomon IH, Huettner JE, Harris DA. Neurotoxic mutants of the prion protein induce spontaneous ionic currents in cultured cells. J Biol Chem 2010; 285:26719-26; PMID:20573963; http://dx.doi.org/10.1074/jbc.M110.134619.
18. Solomon IH, Khatri N, Biasini E, Massignan T, Huettner JE, Harris DA. An N-terminal polybasic domain and cell surface localization are required for mutant prion protein toxicity. J Biol Chem 2011; 286:14724-36; PMID:21385869; http://dx.doi.org/10.1074/jbc.M110.214973.
19. Wadia JS, Schaller M, Williamson RA, Dowdy SF. Pathologic prion protein infects cells by lipid-raft dependent macropinocytosis. PLoS One 2008; 3:3314; PMID:19390657; http://dx.doi.org/10.1371/journal.pone.0003314.
20. Gump JM, Dowdy SF. TAT transduction: the molecular mechanism and therapeutic prospects. Trends Mol Med 2007; 13:443-8; PMID:17913584; http://dx.doi.org/10.1016/j.molmed.2007.08.002.
21. Warner RG, Hundt C, Weiss S, Turnbull JE. Identification of the heparan sulfate binding sites in the cellular prion protein. J Biol Chem 2002; 277:18421-30; PMID:11882649; http://dx.doi.org/10.1074/jbc.M110406200.
22. Taylor DR, Whitehouse IJ, Hooper NM. Glypican-1 mediates both prion protein lipid raft association and disease isoform formation. PLoS Pathog 2009; 5:1000666; PMID:19936054; http://dx.doi.org/10.1371/journal.ppat.1000666.
23. Shyng SL, Heuser JE, Harris DA. A glycolipid-anchored prion protein is endocytosed via clathrin-coated pits. J Cell Biol 1994; 125:1239-50; PMID:7911471; http://dx.doi.org/10.1083/jcb.125.6.1239.
24. Shyng SL, Moulder KL, Lesko A, Harris DA. The N-terminal domain of a glycolipid-anchored prion protein is essential for its endocytosis via clathrin- coated pits. J Biol Chem 1995; 270:14793-800; PMID:7782345; http://dx.doi.org/10.1074/jbc.270.24.14793.
25. Harris DA. Trafficking, turnover and membrane topology of PrP. Br Med Bull 2003; 66:71-85; PMID:14522850; http://dx.doi.org/10.1093/bmb/66.1.71.
26. Parkin ET, Watt NT, Turner AJ, Hooper NM. Dual mechanisms for shedding of the cellular prion protein. J Biol Chem 2004; 279:11170-8; PMID:14711812; http://dx.doi.org/10.1074/jbc.M312105200.
27. Shmerling D, Hegyi I, Fischer M, Blättler T, Brandner S, Götz J, et al. Expression of amino-terminally truncated PrP in the mouse leading to ataxia and specific cerebellar lesions. Cell 1998; 93:203-14; PMID:9568713; http://dx.doi.org/10.1016/S0092-8674(00)81572-X.
28. Baumann F, Tolnay M, Brabeck C, Pahnke J, Kloz U, Niemann HH, et al. Lethal recessive myelin toxicity of prion protein lacking its central domain. EMBO J 2007; 26:538-47; PMID:17245436; http://dx.doi.org/10.1038/sj.emboj. 7601510.
29. Telling GC, Haga T, Torchia M, Tremblay P, DeArmond SJ, Prusiner SB. Interactions between wild-type and mutant prion proteins modulate neurodegeneration in transgenic mice. Genes Dev 1996; 10:1736-50; PMID:8698234; http://dx.doi.org/10.1101/gad.10.14.1736.
30. Rodriguez MM, Peoc'h K, Haïk S, Bouchet C, Vernengo L, Mañana G, et al. A novel mutation (G114V) in the prion protein gene in a family with inherited prion disease. Neurology 2005; 64:1455-7; PMID:15851745; http://dx.doi.org/10.1212/01.WNL.0000158618.39527.93.
31. Chiesa R, Piccardo P, Ghetti B, Harris DA. Neurological illness in transgenic mice expressing a prion protein with an insertional mutation. Neuron 1998; 21:1339-51; PMID:9883727; http://dx.doi.org/10.1016/S0896-6273(00)80653-4.
32. Dossena S, Imeri L, Mangieri M, Garofoli A, Ferrari L, Senatore A, et al. Mutant prion protein expression causes motor and memory deficits and abnormal sleep patterns in a transgenic mouse model. Neuron 2008; 60:598-609; PMID:19038218; http://dx.doi.org/10.1016/j.neuron.2008.09.008.
33. Christensen HM, Dikranian K, Li A, Baysac KC, Walls KC, Olney JW, et al. A highly toxic cellular prion protein induces a novel, nonapoptotic form of neuronal death. Am J Pathol 2010; 176:2695-706; PMID:20472884; http://dx.doi.org/10.2353/ajpath.2010.091007.
34. Muramoto T, Scott M, Cohen FE, Prusiner SB. Recombinant scrapie-like prion protein of 106 amino acids is soluble. Proc Natl Acad Sci USA 1996; 93:15457-62; PMID:8986833; http://dx.doi.org/10.1073/pnas.93.26.15457.
35. Hölscher C, Delius H, Bürkle A. Overexpression of nonconvertible PrPC delta114-121 in scrapie-infected mouse neuroblastoma cells leads to trans-dominant inhibition of wild-type PrP(Sc) accumulation. J Virol 1998; 72:1153-9; PMID:9445012.
36. Norstrom EM, Mastrianni JA. The AGA AAA GA palindrome in PrP is required to generate a productive PrPSc-PrPC complex that leads to prion propagation. J Biol Chem 2005; 280:27236-43; PMID:15917252; http://dx.doi.org/10.1074/jbc. M413441200.
37. Trevitt CR, Collinge J. A systematic review of prion therapeutics in experimental models. Brain 2006; 129:2241-65; PMID:16816391; http://dx.doi.org/10.1093/brain/awl150.
38. Laurén J, Gimbel DA, Nygaard HB, Gilbert JW, Strittmatter SM. Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Nature 2009; 457:1128-32; PMID:19242475; http://dx.doi.org/10.1038/nature07761.
39. Resenberger UK, Harmeier A, Woerner AC, Goodman JL, Müller V, Krishnan R, et al. The cellular prion protein mediates neurotoxic signalling of β-sheet-rich conformers independent of prion replication. EMBO J 2011; 30:2057-70; PMID:21441896; http://dx.doi.org/10.1038/emboj.2011.86.
40. Yang W, Cook J, Rassbach B, Lemus A, DeArmond SJ, Mastrianni JA. A New Transgenic Mouse Model of Gerstmann-Straussler-Scheinker Syndrome Caused by the A117V Mutation of PRNP. J Neurosci 2009; 29:10072-80; PMID:19675240; http://dx.doi.org/10.1523/JNEUROSCI.2542-09.2009.